Synthesis and antibacterial activity of novel curcumin derivatives containing heterocyclic moiety

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue 1, 2013, Pages 47-56

  Hamed, Othman A ^a   Mehdawi, Noha ^a   Taha, Adham Abu ^a   Hamed, Emad M ^b   Al Nuri, Mohammed A ^a   Hussein, Ayman S ^a  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

^b HASHEMITE UNIVERSITY   (Jordan)

Author keywords

Antimicrobial activity; Diazepine; Disc diffusion; Isoxazoles; Keywords; Pyrazoles

Indexed keywords

1 (5 CHLORO 1 NAPHTHALENESULFONYL) HEXAHYDRO 1H 1, 4 DIAZEPINE; AMPICILLIN; CARBENICILLIN; CURCUMIN; ISOXAZOLE; METICILLIN; PYRAZOLE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CURCUMA; DISK DIFFUSION; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PURIFICATION; THIN LAYER CHROMATOGRAPHY;

EID: 84874726748     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Travis J. Reviving the antibiotics miracle? Science (1994) 264:360-362.
2. Hata K, Hata J, Miki HT, Toyosawa T, Nakamura T and Katsu K. In-vitro and in-vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob. Agents Chemother. (1996) 40: 2237-2242.
3. Sugawara T, Shibazaki M, Nakahara H and Suzuki K. YM-47522, a novel antifungal antibiotic produced by Bacillus sp. II. Structure and relative stereochemistry. J. Antibiot. (Tokyo) (1996) 49: 345-348.
4. Moellering R C. Vancomycin-Resistant Enterococci. Clin. Infect. Dis. (1998), 26, 1196-1199.
5. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science (1994) 264: 375-382.
6. Thomson J M and Bonomo R. A. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! Curr Opin Microbiol. (2005) 8: 518-524.
7. Ammon HP and Wahl MA. Pharmacology of curcuma longa. Planta Med. (1991) 57: 1-7.
8. Eigner DD and Scholz J. Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. Ethnopharmacol. Ethnopharmacol. (1999) 67: 1-6.
9. M Rezvani. Extract of Curcuma longa in the treatment of radiation lesions. Iranian J. Pharm. Res. (2004) Suppl: 78
10. Lodha R and Baga A. Traditional Indian systems of medicine. Ann. Acad. Med. Singapore (2000) 29: 37-41.
11. Aggarwal BB, Kumar A and Bharti AC. Anticancer Potential of Curcumin: Preclinical and Clinical Studies. Anticancer Res. (2003) 23: 363-398.
12. Prusty BK and Das BC. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int. J. Cancer (2005) 113:951-960.
13. Prusty BK, Husain SA and Das BC. Constitutive activation of nuclear factor -kB: preferntial homodimerization of p50 subunits in cervical carcinoma. Front. Biosci. (2005) 10: 1510-1519.
14. Sharma OP. Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol. (1976) 25: 1811-1812.
15. Holder GM, Plummer JL and Ryan AJ. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica (1978) 8: 761-768.
16. Mukhopadhyay A, Basu N, Ghatak N and Gujral PK. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions (1982) 12: 508-512.
17. Squires MS, Hudson EA, Howells L, Sale S, Houghton CE, Jones JL, Fox LH, Dickens M, Prigent SA and Manson MM. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/ protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem. Pharmacol. (2003) 65: 361-376.
18. Duvoix R, Blasius S, Delhalle M, Schnekenburger F, Morceau E, Henry M, Dicato M, and Diederich M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. (2005) 223: 181-190.
19. Martono S. Inhibitory Effects of Curcumin and its Analogs on In Vitro Rat Liver Glutathione S -Transferases Activity. Chem. Abstract (1996) 128: 110377.
20. Rajakumar DV and Rao MN. Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates. Mol Cell Biochem. (1994) 140: 73-79.
21. Kiran B, Tripathy BC and Sharma D. Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology (2006) 7: 81-89.
22. Rajkrishnan V, Vishwanathan P, Rajasekharan KN and Menon VP. Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage. Phytother Res. (1999) 13: 571-574.
23. Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Herris-White ME and Cole GM. Phenolic anti-inflammatory anti- oxidant reversal of a beta-induced cognitive deficits and neuropathology. Neurobiol Aging. (2001) 22: 993-1005.
24. Calabrese V, Butterfeld DA and Stella AM. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: Novel targets for neuroprotection in Alzheimer>s disease. Ital. J. Biochem. (2003) 52: 177-181.
25. Senior K. FDA approves frst drug in new class of antibiotics. The Lancet (2000) 355: 1523.
26. Lin AH, Murray RW, Vidmar TJ and Marotti KR. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob. Agents Chemother. (1997) 41: 2127-2131.
27. Diekema DJ and Jones R N. Oxazolidinone antibiotics. The Lancet (2001) 358: 1975-1982.
28. Hancock RE. Mechanisms of action of newer antibiotics for Gram-positive pathogens. Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect. Dis. (2005) 5: 209-218.
29. Stevens DL, Dotter B, Madaras K. Review of linezolid: the first oxazolidinone antibiotic. Exp. Rev. Ant. Infect. Ther. (2004) 2: 51-59.
30. Mazumder M, Raghavan K, Weinstein J, Kohn KW and Pommier Y. Inhibition of human immunodefciency virus type-1 integrase by curcumin. Biochem. Pharmacol. (1995) 49: 1165-1170.
31. Sui Z, Salto R, Li J, Craik C, Ortiz de Montellano PR. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes. Bioorg. Med. Chem. (1993) 1: 415-422.
32. Wang M, Wang LF, Li YZ, Li QX, Xu ZD and Qu DM. Antitumour activity of transition metal complexes with the thiosemicarbazone derived from 3-acetylumbelliferone. Trans. Met. Chem. (2001) 26:307-310.
33. Yadav LDS and Singh S. Synthesis of antiviral acyclic C-nucleosides incorporating thiazolo-1,3,4-oxa(thia) diazole or thiazolo-1,2,4-triazole structure as a nucleobase Indian J. Chem. (2001) 40B: 440-442.
34. Hans N. Swiss Patent (1977) No 592103. [Chem. Abstr. (1978) 88: 22886].
35. Wilson KJ, Utig CR, Subhasinghe N, Hoffman JB, Rudolph NJ, Soll R, Molloy CJ, Bone R, Green D and Randall J. Synthesis of thiophene-2-carboxamidines containing 2-aminothiazoles and their biological evaluation as urokinase inhibitors. Bio-Org Med. Chem. Lett. (2001) 11: 915-918.
36. Berlin KD and Herd MD. Novel 2-Amino-4-Aryl-Substituted-and 2-Amino-4,5-Disubstituted-Thiazoles. Proc. Okala. Acad. Sci. (1991) 71: 29-33.
37. Iovu M, Zalaru C, Dumitrascu F, Draghici C, Moraru M and Criste E. New substituted 2-(pyrazol-1-yl)-dialkylacetanilides with potential local anesthetic and antiarrhythmic action. Part II. Farmaco (2003) 58: 301-307.
38. Mahajan RN, Havaldar FH and Fernandes PS. Synthesis and Biological Activity of Heterocycles Derived from 3-Methoxy-I-Phenyl-IH-Pyrazole-5-Carboxylate. J. Indian Chem. Soc. (1991) 68: 245-249.
39. Baraldi PG, Manfredini S, Romagnoli R, Stevanato L, Zaid AN and Manservigi R. Nucleos. Nucleot. Nucleic Acids (1998) 17: 2165-2171.
40. Bruno O, Bondavalli F, Ranise A, Schenone P, Losasso C, Cilenti L, Matera C and Marmo E. 3,5-Diphenyl-1H-pyrazole derivatives. V-1-Acetyl-4-hydroxy-3,5-diphenyl-2-pyrazoline esters, 4-hydroxy-3,5-diphenyl-1H-pyrazole esters and N-substituted 4-(3-amino-2-hydroxy-1-propoxy)-1-methyl-3,5-diphenyl-1H-pyrazoles with antiarrhythmic, sedative and platelet antiaggregating activities. Farmaco (1990) 45: 147-166.
41. Cottineau B, Toto P, Marot C, Pipaud A and Chenault J. Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids. Bioorg. Med. Chem. Lett. (2002) 12: 2105-2108.
42. Smith SR, Denhardt G and Terminelli C. The anti-inflammatory activities of cannabinoid receptor ligands in mouse peritonitis models. Eur. J. Pharmacol. (2001) 432: 107-119.
43. Varshney V, Mishra NN, Shukla PK, Sahu P and Devi, P. Synthesis and antibacterial evaluation of isoxazolinyl oxazolidinones: Search for potent antibacterial. Bioorg. Med. Chem. Lett. (2009) 19: 3573-3576.
44. Lin AH, Murray RW, Vidmar TJ and Marotti KR. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob. Agents Chemother. (1997) 41: 2127-2131.
45. Hancock RE. Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect. Dis. (2005) 5: 209-218.
46. Stevens DL, Dotter B and Madaras K. Review of linezolid: the frst oxazolidinone antibiotic. Exp. Rev. Ant. Infect. Ther. (2004) 2: 51-59.
47. Gonzales RD, Scherkenberger PC, Graham MB, Kelkar S, Denbesten K and Quinn JP. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. The Lancet (2001) 357: 1179.
48. Schutz H. Benzodiazepines. (Springer, Heidelberg, Germany, 1982)
49. Landquist JK, In: Katritzky AR, C.W. Rees (Eds.) Comprehensive Heterocyclic Chemistry (Pergamon, Oxford, UK 1984) 166-170.
50. Fryer RI, In: Taylor EC. (Ed.), Bicyclic Diazepines. In Comprehensive Heterocyclic Chemistry (Wiley, New York, 1991).
51. Randall LO and Kappel B, In: Garattini S, Musini E, Randall LO. (Eds.), Benzodiazepines (Raven Press, New York, 1973) 27.
52. Amolins MW, Peterson LB and Blagg BS. Synthesis and evaluation of electron-rich curcumin analogues. J. Bioorg. and Med. Chem. (2009) 17: 360-367.
53. Bapat BA, Shirote P J and Tanavade SS. Substituted and Annulated 1,4-Diazepines-Synthesis and Characterization. Int. J. of Med. and Pharm. Sci. (2011) 1: 28-35.
54. Kumar R and Joshi YC. Synthesis, antimicrobial and antifungal activities of novel 1H-1,4-diazepines containing pyrazolopyrimidinone moiety. J. Chem. Sci. India (2009) 121: 497-502.
55. Perez C, Pauli M and Bazevque P. An antibiotic assay by the agar well diffusion method. Acta Biologiaeet Medicine Experimentalis (1990) 15: 113-115.